WO2017142368A3 - 알레르기성 또는 염증성 피부질환의 예방 또는 치료용 조성물 - Google Patents

알레르기성 또는 염증성 피부질환의 예방 또는 치료용 조성물 Download PDF

Info

Publication number
WO2017142368A3
WO2017142368A3 PCT/KR2017/001808 KR2017001808W WO2017142368A3 WO 2017142368 A3 WO2017142368 A3 WO 2017142368A3 KR 2017001808 W KR2017001808 W KR 2017001808W WO 2017142368 A3 WO2017142368 A3 WO 2017142368A3
Authority
WO
WIPO (PCT)
Prior art keywords
preventing
composition
inflammatory skin
treating allergic
skin disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2017/001808
Other languages
English (en)
French (fr)
Other versions
WO2017142368A2 (ko
Inventor
한명관
오유근
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
STEMDR Inc
Industry Academic Cooperation Foundation of Chonbuk National University
Original Assignee
STEMDR Inc
Industry Academic Cooperation Foundation of Chonbuk National University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by STEMDR Inc, Industry Academic Cooperation Foundation of Chonbuk National University filed Critical STEMDR Inc
Priority claimed from KR1020170021592A external-priority patent/KR20170098182A/ko
Publication of WO2017142368A2 publication Critical patent/WO2017142368A2/ko
Anticipated expiration legal-status Critical
Publication of WO2017142368A3 publication Critical patent/WO2017142368A3/ko
Ceased legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

본 발명은 NED19, 브로모-사이클릭 ADP-리보오스 또는 에모딘을 유효성분으로 포함하는 알레르기성 또는 염증성 피부질환의 예방 또는 치료용 조성물에 관한 것이다. 본 발명의 NED19, 브로모-사이클릭 ADP-리보오스 및 에모딘은 히스타민 의존성 및 히스타민 비의존성 가려움증뿐만 아니라 나아가 아토피 피부염에 의한 가려움증 등 다양한 알레르기성 또는 염증성 피부질환에 대한 예방 및 치료 효과가 우수한 바, 의약품, 피부외용제, 식품 및 화장품 등으로 다양하게 활용될 수 있다.
PCT/KR2017/001808 2016-02-19 2017-02-17 알레르기성 또는 염증성 피부질환의 예방 또는 치료용 조성물 Ceased WO2017142368A2 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR20160019807 2016-02-19
KR10-2016-0019807 2016-02-19
KR1020170021592A KR20170098182A (ko) 2016-02-19 2017-02-17 알레르기성 또는 염증성 피부질환의 예방 또는 치료용 조성물
KR10-2017-0021592 2017-02-17

Publications (2)

Publication Number Publication Date
WO2017142368A2 WO2017142368A2 (ko) 2017-08-24
WO2017142368A3 true WO2017142368A3 (ko) 2018-09-07

Family

ID=59625237

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2017/001808 Ceased WO2017142368A2 (ko) 2016-02-19 2017-02-17 알레르기성 또는 염증성 피부질환의 예방 또는 치료용 조성물

Country Status (1)

Country Link
WO (1) WO2017142368A2 (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3040052C (en) * 2016-10-11 2021-03-23 Industrial Cooperation Foundation Chonbuk National University Use of cadpr or naadp antagonists
CN116747213A (zh) * 2023-06-30 2023-09-15 大连医科大学附属第一医院 大黄素在抑制皮脂腺合成与分泌中的应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000037089A1 (en) * 1998-12-18 2000-06-29 University Of Bath Cyclic adenosine diphosphate ribose analogues for modulating t cell activity
KR100812596B1 (ko) * 2006-12-15 2008-03-13 바이오스펙트럼 주식회사 천연 유래 화합물을 포함하는 피부보호 조성물
KR100832332B1 (ko) * 2007-02-12 2008-05-26 바이오스펙트럼 주식회사 아토피성 피부염 증상을 개선하기 위한 조성물
WO2009156724A2 (en) * 2008-06-25 2009-12-30 Isis Innovation Limited Novel compounds

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000037089A1 (en) * 1998-12-18 2000-06-29 University Of Bath Cyclic adenosine diphosphate ribose analogues for modulating t cell activity
KR100812596B1 (ko) * 2006-12-15 2008-03-13 바이오스펙트럼 주식회사 천연 유래 화합물을 포함하는 피부보호 조성물
KR100832332B1 (ko) * 2007-02-12 2008-05-26 바이오스펙트럼 주식회사 아토피성 피부염 증상을 개선하기 위한 조성물
WO2009156724A2 (en) * 2008-06-25 2009-12-30 Isis Innovation Limited Novel compounds

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LU: "Emodin, a naturally occurring anthraquinone derivative, suppresses IgE-mediated anaphylactic reaction and mast cell activation", BIOCHEMICAL PHARMACOLOGY, vol. 82, 2011, pages 1700 - 1708, XP028329281, DOI: doi:10.1016/j.bcp.2011.08.022 *
WANG WEIMIN ET AL.: "Anti-allergic activity of emodin on IgE-mediated activation in RBL-2H3 cells", PHARMACOLOGICAL REPORTS, vol. 64, 2012, pages 1216 - 1222, XP055601330, ISSN: 1734-1140 *

Also Published As

Publication number Publication date
WO2017142368A2 (ko) 2017-08-24

Similar Documents

Publication Publication Date Title
IL255203B (en) Topical pharmaceutical emulsion compositions comprising 3,5-dihydroxy-4-isopropyl-trans-stilbene and use thereof in the treatment or prophylaxis of dermatological conditions or disorders
WO2017207481A8 (en) Substituted indazoles useful for treatment and prevention of allergic and/or inflammatory diseases in animals
EP4653048A3 (en) Therapeutic use of mitochondria and combined mitochondrial agents
WO2018026722A8 (en) COMPOSITIONS AND METHODS FOR INHIBITING MASP-3 FOR THE TREATMENT OF VARIOUS DISEASES AND DISORDERS
WO2016172658A3 (en) Microbiome regulators and related uses thereof
WO2017194782A3 (en) Therapeutic targeting of non-cellular structures
AU2018264384A1 (en) Solid forms of berberine ursodeoxycholate and compositions and methods thereof
WO2016190683A8 (ko) 길경 추출물을 함유하는 근육 질환 예방 및 치료용 또는 근 기능 개선용 조성물
WO2019040106A3 (en) COMPOUNDS, RELATED SALTS AND METHODS FOR THE TREATMENT OF DISEASES
HK1244616A2 (zh) 一组保湿组合及其在制备保湿化妆品的应用
PH12017500706B1 (en) Composition containing extract or fraction of genus justicia plant
WO2015061798A3 (en) Compositions and methods comprising yeast organisms and lipid extracts thereof
WO2016191458A3 (en) Pharmaceutical compositions affecting mitochondrial redox state and methods of treatment
CR20180540A (es) 5,6,7,8–tetrahidro[1,2,4]triazolo[4,3–a]piridin–3(2h)–onas y 2,5,6,7-tetrahydro-3h-pyrrolo[2,1-c][1,2,4]triazol-3-ones sustituidas su uso
WO2015117841A3 (en) Meta-stable o/w emulsions
WO2016142708A3 (en) Pharmaceutical composition
WO2017121646A8 (en) 3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
EP4574832A3 (en) Dantrolene prodrugs and methods of their use
EP4272832A3 (en) Antimicrobial compounds, compositions, and uses thereof
WO2017037075A8 (de) Zusammensetzung enthaltend einen extrakt aus echinacea und linolsäurederivate
WO2015106215A3 (en) Pharmaceutical compositions comprising 15-hepe and methods of treating asthma and lung disorders using same
WO2018081183A3 (en) Maca compositions and methods of use
WO2016161990A3 (zh) 用于治疗心血管疾病的固体制剂
WO2013153108A3 (en) Embelia concinna extract comprising flavonoids in cosmetic and pharmaceutical compositions
WO2017036488A8 (fr) Produit de combinaison pour aider a la relaxation et a l'endormissement

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17753529

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 17753529

Country of ref document: EP

Kind code of ref document: A2